SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
The prescribed route of administration for each Systemic Anti-Cancer Therapy Drug Administration in a Systemic Anti-Cancer Therapy Drug Cycle.
Format / Length
an2
Description
National Codes
Code | Description |
---|---|
01 |
Intravenous |
02 |
Oral |
03 |
Intrathecal |
04 |
Intramuscular |
05 |
Subcutaneous |
06 |
Intraarterial |
07 |
Intraperitoneal |
08 |
Other intracavity Intracavernous |
09 |
Intravesical (Intra-Vesicular) |
10 |
Intratumour / Intralesional (Retired 1 September 2019 ) |
11 |
Cutaneous (Topical) |
12 |
Intradermal |
13 |
Intratumour |
14 |
Intralesional |
99 |
Other (Retired 1 September 2019 ) |
98 |
Other (not listed) |
Also Known As
This data element is also known by these names:
Context | Alias |
---|---|
Plural | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTES OF ADMINISTRATION |
Where Used
Type | Link | How used |
---|---|---|
Data Element | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |
Data Set | Systemic Anti-Cancer Therapy Data Set | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |